Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (291-300 of 760) with videos related to

Pageof 76
Sort By:
Stroke|January 5, 2008
A systematic review of outcomes in patients with staged carotid artery stenting and coronary artery bypass graft surgeryLuis A Guzman, Marco A Costa, Dominick J Angiolillo, et al.
Clinical Pharmacokinetics|April 28, 2023
Clinical and Pre-Clinical Pharmacokinetics and Pharmacodynamics of BentracimabLuis Ortega-Paz, Salvatore Giordano, Francesco Franchi, et al.
JAMA Internal Medicine|April 19, 2021
Systematic Assessment of Online Health Information for Coronary RevascularizationIrbaz Hameed, N U Farrukh Hameed, Christian T Oakley, et al.
Circulation. Cardiovascular Interventions|July 9, 2015
Ticagrelor Versus Clopidogrel in Black Patients With Stable Coronary Artery Disease: Prospective, Randomized, Open-Label, Multiple-Dose, Crossover Pilot StudyRon Waksman, Juan Maya, Dominick J Angiolillo, et al.
Journal of the American College of Cardiology|April 10, 2007
Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectivesDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Expert Review of Cardiovascular Therapy|November 3, 2023
Bivalirudin in acute coronary syndromesMattia Galli, Marco Bernardi, Luis Ortega-Paz, et al.
Thrombosis and Haemostasis|February 16, 2018
Impact of Multidrug Resistance Protein-4 Inhibitors on Modulating Platelet Function and High on-Aspirin Treatment Platelet ReactivityLaura Alemanno, Isabella Massimi, Vanessa Klaus, et al.
American Heart Journal|August 3, 2020
Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double-blinded, placebo-controlled randomized trialYi Li, Quanmin Jing, Bing Wang, et al.
Expert Opinion on Drug Safety|November 10, 2025
Safety and optimal use of direct oral anticoagulant therapyClaudio Laudani, Luis Ortega-Paz, Ali Zgheib, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 18, 2016
The Rationale for and Clinical Pharmacology of Prasugrel 5 mgJoseph A Jakubowski, David Erlinge, Dimitrios Alexopoulos, et al.
Pageof 76

Showing results (291-300 of 760) with videos related to

Sort By:
Pageof 76
Stroke|January 5, 2008
A systematic review of outcomes in patients with staged carotid artery stenting and coronary artery bypass graft surgeryLuis A Guzman, Marco A Costa, Dominick J Angiolillo, et al.
Clinical Pharmacokinetics|April 28, 2023
Clinical and Pre-Clinical Pharmacokinetics and Pharmacodynamics of BentracimabLuis Ortega-Paz, Salvatore Giordano, Francesco Franchi, et al.
JAMA Internal Medicine|April 19, 2021
Systematic Assessment of Online Health Information for Coronary RevascularizationIrbaz Hameed, N U Farrukh Hameed, Christian T Oakley, et al.
Circulation. Cardiovascular Interventions|July 9, 2015
Ticagrelor Versus Clopidogrel in Black Patients With Stable Coronary Artery Disease: Prospective, Randomized, Open-Label, Multiple-Dose, Crossover Pilot StudyRon Waksman, Juan Maya, Dominick J Angiolillo, et al.
Journal of the American College of Cardiology|April 10, 2007
Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectivesDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Expert Review of Cardiovascular Therapy|November 3, 2023
Bivalirudin in acute coronary syndromesMattia Galli, Marco Bernardi, Luis Ortega-Paz, et al.
Thrombosis and Haemostasis|February 16, 2018
Impact of Multidrug Resistance Protein-4 Inhibitors on Modulating Platelet Function and High on-Aspirin Treatment Platelet ReactivityLaura Alemanno, Isabella Massimi, Vanessa Klaus, et al.
American Heart Journal|August 3, 2020
Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double-blinded, placebo-controlled randomized trialYi Li, Quanmin Jing, Bing Wang, et al.
Expert Opinion on Drug Safety|November 10, 2025
Safety and optimal use of direct oral anticoagulant therapyClaudio Laudani, Luis Ortega-Paz, Ali Zgheib, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 18, 2016
The Rationale for and Clinical Pharmacology of Prasugrel 5 mgJoseph A Jakubowski, David Erlinge, Dimitrios Alexopoulos, et al.
Pageof 76